Compound ID | 2842
Synonym(s): Azatricyclic amide-linked pyridooxazinone (1a)
Class: DNA synthesis inhibitor
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Active against methicillin-resistant Staphylococcus aureus, Acinetobacter baumannii, and Escherichia coli; bacterial topoisomerase inhibitor; targets DNA gyrase and topoisomerase IV |
| Description: | Synthetic compound; derived from a tricyclic amine NBTI (2a) which only showed Gram-positive activity, poor hERG inhibition (relates cardiac toxicity) and metabolic stability; shows in vitro cardiac safety (common issue in NBTIs) and extended antibiotic spectrum; additionally inhibits human leukaemia K562 cells |
| Institute where first reported: | Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio, USA |
| Year first mentioned: | 2023 |
| Development status: | Experimental |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| Citations: |
|